COMMUNIQUÉS West-GlobeNewswire

Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
11/03/2019
WALTHAM Mass. and CRESTWOOD, Ky., March 11, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals , Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2018 Financial Results Conference Call and Webcast on March 13, 2019
11/03/2019
THE WOODLANDS, Texas, March 11, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its fourth quarter and full-year 2018 financial results on Wednesday, March 13, 2019 before market [...]
Bavarian Nordic Announces FDA Delay in the Review of the Biologics License Application for MVA-BN Smallpox Vaccine
11/03/2019
COPENHAGEN, Denmark, March 11, 2019 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced that it has received information from the U.S. Food and Drug Administration (FDA) that the review of the Company's [...]
CORRECTING and REPLACING - Yuhan Corp and Sorrento Therapeutics Announce Completion of Phase 1 Clinical Study of Anti-PD-L1 Antibody IMC-001
11/03/2019
Phase 2 Study to Start Later 2019 SEOUL, South Korea and SAN DIEGO, March 11, 2019 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Sorrento Therapeutics, Inc. (Nasdaq: SRNE), please note [...]
ProQR traite le premier patient dans l’essai STELLAR de Phase 1/2 du QR-421a pour le syndrome d’Usher de type 2
11/03/2019
LEIDEN, Pays-Bas et CAMBRIDGE, Massachusetts, 11 mars 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq : PRQR), société consacrée à changer la vie grâce à la création de médicaments ARN transformateurs pour le [...]
Ossur Hf : Transactions in relation to share buyback program
11/03/2019
Announcement no. 18/2019 11 March 2019 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]
Intermountain Healthcare Launches New ‘Intermountain at Home’ Service to Enable Patients to Receive Clinical Care at Home
11/03/2019
Intermountain Healthcare is expanding its home-based services this year to include primary care, some traditional hospital-level services, and palliative care for patients with chronic or serious medical conditions. [...]
Nymox to Host Investor Teleconference
11/03/2019
HASBROUCK HEIGHTS, N.J., March 11, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) will hold a teleconference for shareholders on March 25, 2019. Management will discuss the Company's current [...]
HEALTH FOUNDATION ELECTS OFFICERS TO BOARD OF DIRECTORS
11/03/2019
J. Everett Wilson Esq. Elected Board Chairman Miami, FL, March 11, 2019 (GLOBE NEWSWIRE) -- Health Foundation of South Florida announced that J. Everett Wilson Esq., a shareholder at AmLaw 100 firm Polsinelli, has been [...]
Xbrane Biopharma informs that trading in subscription rights and interim shares is delayed and will be initiated 12 March 2019
11/03/2019
Press release 11 March 2019 The Board of Directors in Xbrane Biopharma AB (publ) ("Xbrane" or the "Company") has today been informed that the Companys subscription rights and interim shares (Ticker: XBRANE TR, ISIN: [...]
Lumere Lands on Crain’s “2019 Best Places to Work in Chicago” List
11/03/2019
CHICAGO, March 11, 2019 (GLOBE NEWSWIRE) -- Lumere, Inc., a leading provider of evidence-based analytics and services to reduce costly and unwarranted variation in drugs and medical devices, has been named one of the [...]
HOOPP 2018 Results: Delivering on the pension promise to our members
11/03/2019
Funded status is 121% and net assets increased to $79B TORONTO, March 11, 2019 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan (HOOPP) announced today that its net assets reached $79.0 billion at the end of [...]
ActivX Biosciences reports key findings that could impact the use of clinically approved CDK4/6 inhibitors in the treatment of cancer patients
11/03/2019
LA JOLLA, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- ActivX Biosciences, Inc., a wholly-owned subsidiary of Kyorin Pharmaceutical Co., Ltd. (Tokyo), announces a report published in a high profile, peer-reviewed journal [...]
Resverlogix Announces Participation at Prominent Industry and Investor Conferences
11/03/2019
CALGARY, Alberta, March 11, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) announced today its participation at leading industry and investor conferences during the month of March [...]
5 Influential Companies In CBD-Infused Beverages
11/03/2019
VANCOUVER, British Columbia, March 11, 2019 (GLOBE NEWSWIRE) -- As consumer awareness around CBD continues to grow, cannabis companies are beginning to allocate an inordinate amount of investment capital into the [...]
Auxly Congratulates Streaming Partner Lotus Ventures on Obtaining Cannabis Licences From Health Canada
11/03/2019
VANCOUVER, British Columbia, March 11, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") today announced that its streaming partner, Lotus Ventures Inc. (“ Lotus ”), has [...]
Auris Medical Announces Publication of AM-111 Phase 3 Results in Peer-Reviewed Scientific Journal
11/03/2019
Zug, Switzerland, March 11, 2019 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous [...]
CORRECTION - Exactus Announces Agricultural Diversification with Entry Into 200 Acre Farming Project for 2019 Grow Season – Promotion of Emiliano Aloi as President
11/03/2019
“Exactus One World” Heralds Fully Diversified Strategy and Propels Exactus to Forefront of Rapidly Evolving CBD Industry GLEN ALLEN, Va., March 11, 2019 (GLOBE NEWSWIRE) -- This release corrects and replaces the version [...]
Precipio CEO Issues Shareholder Update Letter
11/03/2019
NEW HAVEN, Conn., March 11, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), issues the following letter from CEO Ilan Danieli. Dear Shareholders, Following our recent quarterly [...]

Pages